Replies to post #100361 on Biotech Values

[rwdm]

Another brand new PCT from Momenta is on : GAL-ALPHA-1,3-GAL-CONTAINING N-GLYCANS IN GLYCOPROTEIN PRODUCTS DERIVED FROM CHO CELLS
(see http://www.wipo.int/pctdb/en/fetch.jsp?LANG=ENG&DBSELECT=PCT&SERVER_TYPE=19-10&SORT=11306650-KEY&TYPE_FIELD=256&IDB=0&IDOC=2124753&C=10&ELEMENT_SET=B&RESULT=1&TOTAL=1&START=1&DISP=25&FORM=SEP-0/HITNUM,B-ENG,DP,MC,AN,PA,ABSUM-ENG&SEARCH_IA=US2009031678&QUERY=%28WO%2f10085251%29+)
The glycoprotein that is analyzed in this PCT is Orencia. This may mean that Momenta is or was (dropped M178?) developing biosimilar Orencia.